Patent details

EP1442024 Title: AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3Üg(b) INHIBITORS

Basic Information

Publication number:
EP1442024
PCT Application Number:
PCT/EP/2002/012079
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP028023075
PCT Publication Number:
WO/2003/037877
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3Üg(b) INHIBITORS
French Title of Invention:
DERIVES D'AMINOBENZAMIDE UTILES COMME INHIBITEURS DE LA GLYCOGENE SYNTHASE KINASE 3ÜG(B)
German Title of Invention:
AMINOBENZAMIDDERIVATE ALS INHIBITOREN DER GLYCOGENSYNTHASEKINASE-3-
SPC Number:

Dates

Filing date:
29/10/2002
Grant date:
19/03/2008
EP Publication Date:
19/03/2008
PCT Publication Date:
08/05/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/08/2004
EP B1 Publication Date:
19/03/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/10/2018
Expiration date:
29/10/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/10/2002
 
 

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:
VAN MALDEREN MICHEL
From:
19/05/2008
Address:
ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KOYMANS Lucien M. H., Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

2

Name:
MERCKEN Marc H., Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

3

Name:
LUDOVICI Donald W., Janssen Pharmaceutica Inc.
Address:
United States (US)

4

Name:
GEERTS Hugo A. G.
Address:
United States (US)

5

Name:
JANSSEN Maroussia, Godelieve, Frank
Address:
Belgium (BE)

6

Name:
EMBRECHTS Werner C. J., Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

7

Name:
KUKLA Michael J.
Address:
United States (US)

8

Name:
JANSSEN Paul A. J. (deceased)
Address:
Belgium (BE)

9

Name:
NUYDENS Rony M., Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

10

Name:
JANSSEN Jasmine, Josee, Werner
Address:
Belgium (BE)

11

Name:
LEWI Paulus Joannes, Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

12

Name:
HEERES Jan, Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

13

Name:
DAEYAERT Frederik F. D., Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

14

Name:
DE JONGE Marc R., Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

15

Name:
BUIJNSTERS Peter J. J. A., Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

16

Name:
JANSSEN Herwig, Josephus, Margareta
Address:
Belgium (BE)

17

Name:
ARTS Theodora, Joanna, Francisca
Address:
Belgium (BE)

18

Name:
JANSSEN Paul, Peter, Maria
Address:
Belgium (BE)

19

Name:
FREYNE Eddy J. E., Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

20

Name:
WILLEMS Marc, Janssen Pharmaceutica N.V.
Address:
Belgium (BE)

Priority

Priority Number:
01204192
Priority Date:
01/11/2001
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 239/30;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
09/10/2017
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1